Glucodrive PG 1mg/500mg/15mg Tablet ER
Marketer
Addii Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glucodrive PG 1mg/500mg/15mg Tablet ER
DiaBeta-PG 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and frequency for DiaBeta-PG 1mg/500mg/15mg ER Tablets; take with food to prevent gastrointestinal distress. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. Overdosing can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; monitor blood glucose regularly. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be conducted before treatment commences. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Glucodrive PG 1mg/500mg/15mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Glucodrive PG 1mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Glucodrive PG 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glucodrive PG 1mg/500mg/15mg Extended-Release Tablets should be administered with food.
Common Side effects of Glucodrive PG 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glucodrive PG 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glucodrive PG 1mg/500mg/15mg Extended-Release Tablets should be administered with meals.
How Glucodrive PG 1mg/500mg/15mg Tablet ER works:
Glucodrive PG 1mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glucodrive PG 1mg/500mg/15mg Tablet ER with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glucodrive PG 1mg/500mg/15mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glucodrive PG 1mg/500mg/15mg tablets pose a likely risk during lactation. Available human data indicate potential drug transfer to breast milk, potentially harming the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glucodrive PG 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glucodrive PG 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. The use of Glucodrive PG 1mg/500mg/15mg Extended-Release tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glucodrive PG 1mg/500mg/15mg Tablet ER :
Should you forget a Glucodrive PG 1mg/500mg/15mg Extended-Release Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glucodrive PG 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently